Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00266968 · ClinicalTrials.gov registry record
Outcomes of Children With Congenital Single Ventricle Heart
A clinical trial, sponsored by Children's Healthcare of Atlanta.
- Completed
- Registry status
- 200
- Enrollment target
NCT00266968: Completed study, sponsored by Children's Healthcare of Atlanta.
NCT00266968 is a clinical trial that has completed, run by Children's Healthcare of Atlanta. The registered enrollment target is 200 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00266968 has completed, sponsored by Children's Healthcare of Atlanta.
- COMPLETED
- Registry status
- 200 participants
- Enrollment target
Study Summary
Congenital heart disease affects 1 in 100 newborn babies each year and more than 2,000,000 Americans have a congenital heart defect. One common defect treated at Children's Healthcare of Atlanta at Egleston is single ventricle heart. Due to these overwhelming numbers, the use of diagnostic imaging technology to assess these defects and heart function is an important step in the evolving care of this patient group.
Primary Outcome
We propose to do a retrospective chart review of patient data including a review of their invasive and non-invasive studies.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 200 participants |
| Start Date | 2000-01 |
| Est. Completion | 2013-12 |
What the finished NCT00266968 record still lists
NCT00266968 is an observational study that tracks outcomes without assigning an intervention. The registered 200 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 0 interventions.
NCT00266968 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00266968 about?
NCT00266968 is a clinical study titled "Outcomes of Children With Congenital Single Ventricle Heart". Congenital heart disease affects 1 in 100 newborn babies each year and more than 2,000,000 Americans have a congenital heart defect. One common defect treated at Children's Healthcare of Atlanta at Egleston is single ventricle heart. Due to these overwhelming numbers, the use of diagnostic imaging t...
What is the current status of trial NCT00266968?
This trial is currently completed. The enrollment target is 200 participants. The study started on 2000-01. Estimated completion is 2013-12.
Who is sponsoring clinical trial NCT00266968?
This trial is sponsored by Children's Healthcare of Atlanta, which has 80 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00107289 · 200 participants · Phase 2
Iodine I 131 Metaiodobenzylguanidine in Treating Patients With Recurrent, Progressive, or Refractory Neuroblastoma or Malignant Pheochromocytoma or Paraganglioma
- NCT00109174 · 200 participants · NA
MRS Measurement of Glutamate and GABA Metabolism in Brain
- NCT00177268 · 200 participants
Blood, Urine, and Tissue Collection for Cutaneous Lymphoma, Eczema, and Atopic Dermatitis Research
- NCT00493688 · 200 participants
A Study to Determine Whether Perioperative Energy Dynamics Correlates With Postoperative Outcomes
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia